文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Prevalence of mental disorders in China: a cross-sectional epidemiological study.

作者信息

Huang Yueqin, Wang Yu, Wang Hong, Liu Zhaorui, Yu Xin, Yan Jie, Yu Yaqin, Kou Changgui, Xu Xiufeng, Lu Jin, Wang Zhizhong, He Shulan, Xu Yifeng, He Yanling, Li Tao, Guo Wanjun, Tian Hongjun, Xu Guangming, Xu Xiangdong, Ma Yanjuan, Wang Linhong, Wang Limin, Yan Yongping, Wang Bo, Xiao Shuiyuan, Zhou Liang, Li Lingjiang, Tan Liwen, Zhang Tingting, Ma Chao, Li Qiang, Ding Hua, Geng Hongchun, Jia Fujun, Shi Jianfei, Wang Shiliang, Zhang Ning, Du Xinbai, Du Xiangdong, Wu Yue

机构信息

Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

出版信息

Lancet Psychiatry. 2019 Mar;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X. Epub 2019 Feb 18.


DOI:10.1016/S2215-0366(18)30511-X
PMID:30792114
Abstract

BACKGROUND: The China Mental Health Survey was set up in 2012 to do a nationally representative survey with consistent methodology to investigate the prevalence of mental disorders and service use, and to analyse their social and psychological risk factors or correlates in China. This paper reports the prevalence findings. METHODS: We did a cross-sectional epidemiological survey of the prevalence of mental disorders (mood disorders, anxiety disorders, alcohol-use and drug-use disorders, schizophrenia and other psychotic disorders, eating disorder, impulse-control disorder, and dementia) in a multistage clustered-area probability sample of adults from 157 nationwide representative population-based disease surveillance points in 31 provinces across China. Face-to-face interviews were done with a two-stage design by trained lay interviewers and psychiatrists with the Composite International Diagnostic Interview, the Structured Clinical Interview for DSM-IV Axis I disorders, the Community Screening Instrument for Dementia from the 10/66 dementia diagnostic package, and the Geriatric Mental State Examination. Data-quality control procedures included logic check by computers, sequential recording check, and phone-call check by the quality controllers, and reinterview check by the psychiatrists. Data were weighted to adjust for differential probabilities of selection and differential response as well as to post-stratify the sample to match the population distribution. FINDINGS: 32 552 respondents completed the survey between July 22, 2013, and March 5, 2015. The weighted prevalence of any disorder (excluding dementia) was 9·3% (95% CI 5·4-13·3) during the 12 months before the interview and 16·6% (13·0-20·2) during the participants' entire lifetime before the interview. Anxiety disorders were the most common class of disorders both in the 12 months before the interview (weighted prevalence 5·0%, 4·2-5·8) and in lifetime (7·6%, 6·3-8·8). The weighted prevalence of dementia in people aged 65 years or older was 5·6% (3·5-7·6). INTERPRETATION: The prevalence of most mental disorders in China in 2013 is higher than in 1982 (point prevalence 1·1% and lifetime prevalence 1·3%), 1993 (point prevalence 1·1% and lifetime prevalence 1·4%), and 2002 (12-month prevalence 7·0% and lifetime prevalence 13·2%), but lower than in 2009 (1-month prevalence 17·5%). The evidence from this survey poses serious challenges related to the high burdens of disease identified, but also offers valuable opportunities for policy makers and health-care professionals to explore and address the factors that affect mental health in China. FUNDING: National Health Commission of Health (Ministry of Health) and Ministry of Science and Technology of China.

摘要

相似文献

[1]
Prevalence of mental disorders in China: a cross-sectional epidemiological study.

Lancet Psychiatry. 2019-3

[2]
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study.

Lancet Psychiatry. 2021-11

[3]
Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey.

Lancet. 2009-6-13

[4]
The prevalence, age-of-onset and the correlates of DSM-IV psychiatric disorders in the Tianjin Mental Health Survey (TJMHS).

Psychol Med. 2017-7-17

[5]
Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey.

Epidemiol Psychiatr Sci. 2015-7-7

[6]
The China Mental Health Survey (CMHS): I. background, aims and measures.

Soc Psychiatry Psychiatr Epidemiol. 2016-11

[7]
Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS).

Psychol Med. 2004-5

[8]
Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011.

Arch Iran Med. 2015-2

[9]
Lifetime prevalence and projected lifetime risk of DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey.

Aust N Z J Psychiatry. 2006-10

[10]
Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries.

Lancet Psychiatry. 2023-9

引用本文的文献

[1]
Case Report: An integrative approach to psychotherapy for the mother of a daughter with bulimia nervosa.

Front Psychiatry. 2025-8-19

[2]
Establishing a long-term predictive model for aggressive behavior in schizophrenia: a 21-year longitudinal study in rural China.

Front Psychiatry. 2025-8-14

[3]
Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism.

BMC Microbiol. 2025-9-1

[4]
Plasma Protein Patterns Associated with Paliperidone Palmitate Maintenance Therapy in Schizophrenia: A Prospective Cohort Study.

CNS Drugs. 2025-8-29

[5]
Medical costs and related factors associated with mental disorders in Jilin Province, China, 2020-2022.

BMC Health Serv Res. 2025-8-28

[6]
The associations between insomnia symptoms and clinical features, lipid metabolism parameters, as well as inflammatory cytokines in patients with chronic schizophrenia.

BMC Psychiatry. 2025-8-28

[7]
Effects of group cognitive behavior therapy on cognitive flexibility in college students with high obsessive-compulsive symptoms.

Front Psychol. 2025-8-12

[8]
Supervised Learning and Large Language Model Benchmarks on Mental Health Datasets: Cognitive Distortions and Suicidal Risks in Chinese Social Media.

Bioengineering (Basel). 2025-8-19

[9]
Perceived Public Stigma Toward Psychological Help: Psychometric Validation of the Stigma Scale for Receiving Psychological Help Among Chinese Law Students.

Behav Sci (Basel). 2025-8-10

[10]
The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge.

Neurol Int. 2025-8-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索